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The mechanisms hypothesized to be responsible for the onset
and maintenance of atrial ﬁbrillation (AF) include pulmo-
nary vein and extrapulmonary vein triggers, atrial remodeling
with associated longitudinal and endo-epicardial dissocia-
tion, and accompanying multiple wavelets with wavebreak
and re-entry, rotor formation, and autonomic modulation of
atrial electrophysiology (1–5). Over the years, these mecha-
nisms have been veriﬁed in human research and serve as
targets for curative ablation of AF, except for rotors. In 2012,
Narayan et al. (6) published spatio-temporal maps derived
from monophasic action potential catheters and 64-pole
unipolar basket endocardial recordings of AF in humans
based on action potential and conduction restitution prop-
erties. These maps contained propagation patterns consistentSee page 138with rotors and focal impulses that could serve as AF sources.
Using this newly developed focal impulse and rotor mapping
(FIRM), these sites were targeted for ablation, which resul-
ted in termination or slowing of AF in the majority of
patients. In the CONFIRM (Conventional Ablation for
Atrial FibrillationWith orWithout Focal Impulse and Rotor
Modulation) trial, AF recurrence was compared between
patients who underwent wide area circumferential ablation
of the pulmonary veins plus FIRM-guided ablation and the
control group who underwent conventional ablation by using
wide area circumferential ablation of the pulmonary veins
with or without a left atrial roof line (7). Ablation incorpo-
rating FIRM maps resulted in signiﬁcantly less recurrence
of AF compared with the control group (17.6% vs. 55.1%;
p < 0.001). FIRM maps were obtained in the conventional
ablation group but were not used for guiding ablation sites.
In this issue of the Journal, Narayan et al. (8) present on-
treatment analysis of 94 patients who completed follow-up in
the CONFIRM trial. Ablation lesion placement on the elec-
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maps by blinded reviewers. The goal was to determine the
degree of directed or coincidental ablationofAF sources in each
patient. They found that 100% of AF sources were ablated in
patients undergoing FIRM-guided ablation, whereas 45% of
AF sources were inadvertently ablated in patients receiving
only conventional ablation. Patients receiving AF source
ablation (inadvertent or intentional) demonstrated a recur-
rence rate of AF of 19.7% compared with 81.8% in patients
without any AF source ablation (p < 0.001). Furthermore,
this effect seemed to follow a dose–response curve, with lower
recurrence rates occurring in those patients with the greatest
number of AF sources eliminated during ablation. AF sources
were located near pulmonary veins (28%), left atrial roof
(16%), and elsewhere in the left (28%) and right (33%) atria.
Interestingly, 51% of all AF sources were located near the
pulmonary vein and left atrial roof in paroxysmal AF patients
compared with only 33.5% in persistent AF patients.
Although these results are impressive (8), there are a few
important limitations of this retrospective analysis. Perhaps
the greatest limitation of the study lies in the interpretation of
the FIRMmaps and assignment of ablation sites as involving
or not involving AF sources. Importantly, the assignments
were performed independently by 4 separate investigators
blinded to demographic characteristics, outcomes, and
assignment into FIRM or conventional ablation arms.
Unfortunately, disputes on assignments were resolved by
consensus, which has the potential to bias the assignment in
question or future assignments and could falsely elevate the
kappa score. In addition, there were varied approaches to
follow-up monitoring, which resulted in greater use of
implantable loop recorders in patients receiving source abla-
tion. Although this would tend to understate the presence of
AF in those patients without source ablation, it is difﬁcult to
conﬁdently compare the implantable loop success cutoff
of <1% AF with the cutoff of <30 s of AF on external
monitors. In addition, it is unexplained why termination and
slowing rates were somuch worse in the conventional ablation
group (20% in CONFIRM) compared with the FIRM-
guided group (86% in CONFIRM). Although the authors
are correct that this ﬁndingmay reﬂect that the FIRM-guided
patients’AF sources were all located and eliminated while the
conventional patients’AF sources were more often only partly
eliminated, 45% of the conventional ablation arm received
incidental AF source ablation that seems out of proportion to
the low termination and slowing rate. Further analysis of this
potential contradiction is needed and, apparently, underway.
These ﬁndings (8) are provocative and potentially impor-
tant. The immediate interpretation is that source ablation
identiﬁed by using FIRM mapping represents a unifying
explanation to the elimination of AF by varying ablation
techniques, including wide area circumferential ablation,
ablation of complex fractionated electrograms, and stepwise
ablation. Successful AF source ablation by other centers using
FIRMmapping has been published in an observational cohort
(9), but the lack of prospective, randomized, multicenter
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149studies still begs the question as to the overall impact this
approach will have on ablation of AF in the population as
a whole. In addition, it is unclear how well the least responsive
patients to ablation (i.e., those with longstanding persis-
tent AF) will respond compared with the paroxysmal and
persistent populations. The impact of FIRM ablation on
longstanding persistent AF versus persistent AF was not
characterized in the CONFIRM trial. The recent ﬁndings
(10) of rotors and focal impulses by using surface electrocar-
diographic imaging and the termination and modulation of
AF with ablation of these AF sources seem to conﬁrm the
ﬁndings by Narayan et al. that rotors and focal impulses are
present and important to the maintenance of AF. Further
investigation as to the best approach regarding the identiﬁ-
cation of rotors is underway, and we will very likely see
evolution of the techniques used (11).
The current investigation by Narayan et al. (8) is intriguing
and adds to the enthusiasm, but it does not settle the skep-
ticism that abounds surrounding the legitimacy and impor-
tance of rotor and focal impulse mapping in the treatment of
AF. The time for a prospective, randomized trial of FIRM
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